Variant report
Variant | nsv10565 |
---|---|
Chromosome Location | chr4:132434274-132436802 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs562263591 | chr4:132435432-132435433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs184896316 | chr4:132435551-132435552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs191022665 | chr4:132435634-132435635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568242371 | chr4:132435635-132435636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs55733408 | chr4:132435663-132435664 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs55680923 | chr4:132435711-132435712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs112234493 | chr4:132435722-132435723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182731308 | chr4:132435755-132435756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs556565239 | chr4:132435775-132435776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533167784 | chr4:132435789-132435790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs187330420 | chr4:132435817-132435818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1511503 | chr4:132435838-132435839 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs111291883 | chr4:132435851-132435852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144105021 | chr4:132435857-132435858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572587791 | chr4:132435869-132435870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534502461 | chr4:132435871-132435872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535018171 | chr4:132435872-132435873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112364087 | chr4:132435882-132435883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532266787 | chr4:132435884-132435885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553182015 | chr4:132435886-132435887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192061689 | chr4:132435902-132435903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539766055 | chr4:132435919-132435920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs369769083 | chr4:132435925-132435926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182945110 | chr4:132435985-132435986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545409802 | chr4:132436013-132436014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535305289 | chr4:132436035-132436036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs562458584 | chr4:132436074-132436075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146478168 | chr4:132436125-132436126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541900772 | chr4:132436142-132436143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs187577979 | chr4:132436173-132436174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527462190 | chr4:132436185-132436186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs77082351 | chr4:132436197-132436198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs143201807 | chr4:132436244-132436245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533225783 | chr4:132436276-132436277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1397860 | chr4:132436283-132436284 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs115244424 | chr4:132436323-132436324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs535613470 | chr4:132436338-132436339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs374098381 | chr4:132436350-132436351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1397861 | chr4:132436391-132436392 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs556990679 | chr4:132436404-132436405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs1397862 | chr4:132436424-132436425 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs113724965 | chr4:132436493-132436494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191649235 | chr4:132436505-132436506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557896400 | chr4:132436510-132436511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs75284452 | chr4:132436566-132436567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs1397863 | chr4:132436590-132436591 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs555928889 | chr4:132436593-132436594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs76704869 | chr4:132436622-132436623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs368205072 | chr4:132436657-132436658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs550502404 | chr4:132436713-132436714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Mental retardation | 17847001 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Mental retardation | 17901693 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:132435400-132436200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr4:132435600-132436200 | Enhancers | Dnd41 | blood |
3 | chr4:132436200-132436600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
4 | chr4:132436600-132437600 | Enhancers | Pancreatic Islets | Pancreatic Islet |